Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trialMona Boaz, Manfred S. Green, Uzi Gafter et al.|The Lancet|2000Cited by 1k
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathyMichal Herman‐Edelstein, Uzi Gafter|Journal of Lipid Research|2013Cited by 627
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and DiabetesXiaoxin X. Wang, Moshe Levi, Michal Herman Edelstein et al.|Journal of the American Society of Nephrology|2015Cited by 208